1/40
Looks like no tags are added yet.
Learning Objectives
Describe the normal micturition cycle
List the physiologic factors responsible for the maintenance of urinary continence
Explain the pathophysiologic basis for the main types of urinary continence
Compare and contrast the clinical presentations of the main types of urinary continence
Identify drugs that can precipitate new-onset or aggravate existing urinary incontinence
Describe the components of the physical examination of a patient undergoing evaluation for urinary incontinence
Discuss diagnostic tests that can assist in the evaluation of patient with urinary incontinence
Compare and contrast nonpharmacologic treatments of the main types of urinary incontinence
List the factors guiding selection of a specific drug for urinary incontinence for an individual patient
Select an appropriate drug for urinary incontinence based on specific data
List factors affecting adherence for a patient receiving drug therapy for urinary incontinence
Formulate a monitoring plan for a patient on drug therapy for urinary incontinence based on a patient-specific information and the prescribed regimen
Formulate appropriate counseling information to be provided to a patient receiving drug therapy for urinary incontinence, given patient-specific information and the prescribing regimen
Which receptors does the bladder have?
Bladder has M1, M2, and M3 receptors
Made up of stretchable smooth muscle (detrusor)
Richly innervated by parasympathetic fibers; specifically muscarinic
Detrusor muscle → controls contraction and relaxation of bladder
Bladder has muscarinic, beta-adrenergic, and alpha-adrenergic receptors
What is the internal sphincter?
Internal sphincter - Not a true sphincter but a continuation of smooth muscle of the bladder
Sympathetic alpha-adrenergic fibers
Facilitates smooth muscle sphincter contraction and relaxation
What is the external sphincter?
Skeletal muscle that is under voluntary control
Allows you to control when/when not to pee
Stimulation of which receptors of the detrusor muscle allows for smooth muscle relaxation of the bladder?
Beta-3
What is micturiton and what are the steps that lead to peeing?
Micturition → the action of urinating
1) The bladder fills
Detrusor muscle relaxes
Urethral sphincter contracts
Pelvic floor contracts
2) First sensation to void
Bladder half full, urination voluntarily inhibited until appropriate time
3) Normal desire to void
4) Micturition
Detrusor muscle contracts
Pelvic floor relaxes
What is the defined as overactive bladder?
Overactive Bladder (OAB)
A medical condition involving:
Sudden, strong urges to urinate
Urinary frequency (> 8 times/day)
Nocturia (> 2 times/night)
Incomplete bladder emptying
Hallmark symptom is urgency to urinate
OAB is a distinct diagnosis involving abnormal nerve signaling or involuntary detrusor contractions
What is defined as urinary incontinence?
Urinary Incontinence (UI)
Involuntary leakage of urine (leakage is primary feature)
Characterized by:
Weakened pelvic floor muscles
Physical stress (coughing, laughing)
Incomplete bladder emptying
Functional limitation
UI is a symptom/outcome as opposed to OAB being a diagnosis
Compare overactive bladder and urinary incontinence

What are the 5 different types of urinary incontinence?
Stress, Urge, Overflow, Functional, and Mixed
What is stress urinary incontinence and what is it caused by?
Involuntary loss of urine (usually in small amounts) with increases in intra-abdominal pressure (which can be caused by coughing, laughing, exercise)
Causes:
Weakness of the pelvic floor musculature and weakness of internal/external urethral sphincter
Sometimes referred to as “urethral underactivity”
Common in younger females after childbirth
What is urge urinary incontinence and what is it caused by?
Large volume urinary leakage because of an inability to delay voiding after sensation of bladder fullness is perceived
Causes:
Idiopathic or unknown
Detrusor instability
CNS disorders, e.g. strokes
Genitourinary conditions
What is overflow urinary incontinence and what is it caused by?
Leakage of urine (usually in small amounts) resulting from mechanical forces on an overly distended bladder or from other effects of urinary retention on bladder and sphincter function
Causes:
Anatomic obstruction → Benign Prostatic Hypertrophy
Neurologic acontractility
Spinal cord injury
Diabetes
Medications
Meds with anticholinergic properties
TCA’s
Antihistamines
Antipsychotics
Opiates
What is functional urinary incontinence and what is it caused by?
Urinary leakage associated with the inability to reach the toilet because of impairment of cognitive and/or physical functioning, psychological unwillingness, or environmental barriers
Causes:
Physical disability
Dementia
Multiple sclerosis
Medications that cause drowsiness or affect balance
What are nonpharm therapies for urinary incontinence?
Pelvic muscle exercises (Kegel exercises)
Minimizing fluid intake ≤ 2 liters/day
Avoidance of caffeinated beve rages, smoking, and alcohol
Minimizing evening fluid intake to reduce likelihood for nocturnal incontinence
Weight loss if overweight (40% effective with SUI)
Take diuretics early in the day to avoid nocturia
What is bladder training?
Bladder training - helps to increase how long a patient can wait before having to urinate
1. Keep a voiding diary for 24 hours
2. Track the shortest time before needing to urinate again
3. Using the shortest time, make a schedule to go the toilet at this interval all day long
4. Go at these times whether feeling the need or not
5. Upon reaching a point in which there is no leaking for a full day, increase schedule by 15 minutes
6. Do this until you are comfortable every 3-4 hours
What are clinical pearls of pharmacologic therapy of UI?
Behavioral therapy is first line for all types of Urinary Incontinence, except in cases of urinary obstruction (BPH and Obstructive uropathies)
For best results, pharmacological therapy should be continued with behavioral therapy after behavioral therapy alone has failed
Drug therapy for Urinary Incontinence is primarily limited to the treatment of Urge Incontinence
Use the lowest doses for the shortest time possible
Drug therapy for urinary incontinence is primarily limited to?
Urge incontinence
Which muscarinic antagonists are used in urinary incontinence?
Oxybutynin
IR (Ditropan)
ER (Ditropan XL)
Transdermal patch (Oxytrol)
Gel (Gelnique)
Tolterodine
IR (Detrol) → Max dose 2mg BID
ER (Detrol LA) → Max dose 4mg once daily
Trospium chloride
IR (Sanctura) → Max: 20mg BID
ER (Sanctura) → Max: 60mg BID
Darifenacin
Solifenacin
Fesoterodine
What are side effects seen with muscarinic receptor antagonists? (oxybutynin, tolterodine, solifenacin)
Anticholinergic AEs: dry mouth, constipation, headache, dyspepsia, dry eyes, blurred vision, cognitive impairment, tachycardia, sedation, orthostatic hypotension
In general: ER, LA, XL and topical products are associated with fewer adverse effects, particularly dry mouth!
What is the MOA of Beta-3 Adrenergic Agonists?
Selective Beta-3 stimulation of the detrusor muscle leading to smooth muscle relaxation and increased bladder capacity
Less dominant pathway, but efficacy demonstrated
Similar moderate efficacy as antimuscarinics
Compare the efficacy of Tolterodine and Oxybutynin
Tolteridine has less anticholinergic adverse effects than oxybutynin
Reasonable 1st line choice in patients prone to anticholinergic effects
What is the role of urinary incontinence agents in patients with dementia?
The risk of using these agents generally outweigh the benefits
Patients with dementia are oftentimes prescribed cholinesterase inhibitors which causes/worsens urge incontinence
Which beta-3 agonists are used for UI?
Mirabegron ER (Mybetriq):
Starting dose: 25mg po once daily
Maximum dose: 50mg po once daily
Vibegron (Gemtesa):
Starting dose: 75mg po once daily
Maximum dose: 75mg po once daily
What are side effects associated with beta3-adrenergic antagonists?
Hypertension, nasopharyngitis, urinary tract infections, headaches
Which UI agents are metabolized by CYP3A4 pathway?
Oxybutynin, Tolterodine, Solifenacin, Darifenacin, and Fesoteridine
Drug interactions: Dose of urinary incontinence medications should be reduced by 50% when administered concomitantly with which medications?
Fluoxetine
Sertraline
Fluvoxamine
Erythromycin, clarithromycin
Itraconazole, ketoconazole
Grapefruit juice
Which UI agent has DIs with antacids?
Tolteridine LA
Coadministration with antacids → 150% elevation in peak levels
Separate time of administration by 4 hours
Which OTC product can be used to treat UI?
Oxytrol for Women
Transdermal oxybutynin patch delivers a steady dose of 3.9 mg/ day over four days
Apply to abdomen, hip, or buttock
Patch is thin, clear and flexible
Helps reduce:
Urinary urgency
Frequency
Incontinence
Night-time urination
May be combined with non-pharm for best results
What is the role of botox in treatment of UI?
May be considered after other treatments (behavioral, medications) fail
FDA-approved for treatment of urge urinary incontinence
Injected into the detrusor muscle of the bladder wall resulting in:
1) bladder relaxation
2) increased storage capacity, and
3) reduced episodes of urinary incontinence
What is the duration of tx of botox and risks of using?
Symptom improvement typically seen within 2-3 weeks; some feel relief within 48 hours
Effects last 6-12 months, with repeat injections as needed
Risks include: urinary retention, UTIs, cramping and discomfort
What is the role of electrical therapies in UI?
Considered after behavioral and pharmacologic therapies
Bladder stimulators
FDA-approved for treatment of stress urinary incontinence
Uses low-grade electrical current to stimulate weak or inactive pelvic muscles to contract
Regular sessions can augment a patient’s pelvic muscle exercise regime
What are the two types of electrical therapies?
1) Sacral Neuromodulation
2) Percutaneous Tibial Nerve Stimulation
Sacral neuromodulation
A small device is implanted under the skin of the buttock
Sends electrical signals to nerves that control bladder and bowel function
Includes trial phase lasting 4-14 days to confirm benefit before implantation
Options
Rechargeable
Recharge-free with battery life up to 15-20 years
Devices
Medtronic InterStim
Axonics SNM
Peripheral Tibial Nerve Stimulation (PTNS)
PTNS therapy typically involves two phases:
Induction phase: 12 weekly sessions, with most patients noticing improvement by the 6th session
Maintenance phase: After successful induction, sessions are spaced every 3-4 weeks or as needed to sustain symptom relief
During 30-minute treatment session:
Small slim needle electrode inserted near the ankle
Needle electrode connected to battery-powered stimulator
Mild impulses from the stimulator travel through needle electrode, along the posterior tibial nerve of the leg, to nerves in the pelvis that control bladder and pelvic floor function
What procedure can be performed for treatment of UI?
Sling procedure
Used for treatment of stress urinary incontinence
Places a thin strip of synthetic mesh under the urethra like a hammock
Provides support for the urethra and bladder neck so they stay closed during coughing, sneezing, lifting, or exercise
Types of sling procedures
Mid-urethral sling (most common)
Traditional Pubovaginal Sling
Male Sling Procedure
Risks: Bleeding, infection, blood clots
What is 1st line therapy for stress urinary incontinence?
Behavioral
Which agents should be AVOIDED in stress urinary incontinence?
1) Oral conjugated estrogens
Increase urinary incontinence rates
Avoid use
2) Oral alpha agonists - No longer recommended due to increased BP and stroke risk
Ephedrine, pseudoephedrine, phenylephrine
3) Alpha blockers
Doxazosin, Terazosin
What is the most common cause of OVERFLOW incontinence in men?
Benign prostatic hyperplasia
Which medications should be avoided in patients with overflow urinary incontinence?
Avoid anticholinergic medications which can lead to acute urinary retention → hydronephrosis → Post-renal failure
How do we differentiate urge vs overflow incontinence?
Post-void residuals (PVR) allow for differentiation:
After urination, a straight urinary catether is placed to empty any residual urine from the bladder → The volume of urine obtained = post-void residual (PVR)
PVR < 50 mL → Probably not overflow incontinence
PVR > 200 mL → May be overflow incontinence
Overflow incontinence is typically accompanied by hesitance when attempting to urinate